As a young, dynamic and creative molecular diagnostics company, we have specialized in simple and rapid solutions for the diagnosis of severe infectious diseases in hospitalized patients. We help to combat infections effectively and detect antibiotic resistance at an early stage.
Curetis Unyvero HPN Application Receives Singapore Health Sciences Authority Approval; Updates on Sepsis Host Response Test
Curetis Group: Ares Genetics Receives Funding Commitment For EUR 1.6 Mio. Project; Curetis Announces Non-Audited Financial Results for 2017
28. Symposium Intensivmedizin + Intensivpflege - Bremen, Germany - 14 to 16 February, 2018
70th Annual Meeting of the German Society for Hygiene and Microbiology (DGHM), Bochum, Germany - February 19 to 21, 2018